Qualderm Partners Grand Rounds

This activity will help educate and review hard and interesting cases on Cutaneous B Cell Follicular Lymphoma of the Leg, BAPoma's/BAP-1 Tumor Predisposition Syndrome, Cutaneous Ovarian Lymphovascular Metastasis and Adiposis dolorosa aka Dercum Disease treated with Kybella and Trental.

Target Audience

This activity is designed for an audience of physicians, physician assistants, nurses and nurse practitioners in the Qualderm Partners network which Includes dermatologists, pathologists, Mohs surgeons and plastic surgeons.

Learning Objectives

 

  • Recognize clinical and pathology features of cutaneous B cell lymphoma
  • Describe the features of BAP-1 tumor predisposition syndrome
  • Recognize cutaneous ovarian lymphovascular metastasis
  • Apply potentially new treatment options in the management of adiposis dolorosa

Commercial Support
There is no commercial support for this activity.

Course summary
Available credit: 
  • 1.00 AANP
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit

    AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC

     

     

     

  • 1.00 Attendance
Course opens: 
03/13/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0
March 17, 2026 Live Virtual
United States

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

 

Course Director(s)

Jake Turrentine, MD

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Kandice Bailey, M.D.

has no relevant financial relationships to disclose at this time.

Rutledge Forney, MD

has no relevant financial relationships to disclose at this time.

Lauren Okon, MD

has no relevant financial relationships to disclose at this time.

Christine Papa, D.O., board certified Dermatologist and fellowship trained Mohs surgeon

has no relevant financial relationships to disclose at this time.

 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Qualderm Partners LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Credit being awarded: 1.0 ANCC contact hours

Physician Associates         

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Qualderm Partners LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.0 contact hour(s) (which includes 0 hour(s) of pharmacology).

Available Credit

  • 1.00 AANP
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit

    AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC

     

     

     

  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.